Article Details

Pfizer Inc (PFE) Faces Headwinds as COVID-19 Product Sales Decline, Yet Reaffirms 2024 Outlook

Retrieved on: 2024-01-30 17:08:31

Tags for this article:

Click the tags to see associated articles and topics

Pfizer Inc (PFE) Faces Headwinds as COVID-19 Product Sales Decline, Yet Reaffirms 2024 Outlook. View article details on hiswai:

Excerpt

Revenue: Full-year 2023 revenue declined by 42% operationally to $58.5 billion, mainly due to decreased sales of COVID-19 products.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up